ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+1.55%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$356M
AUM Growth
+$356M
(-5%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
172
New
47
Increased
12
Reduced
23
Closed
37
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$12.6M |
| 2 |
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
|
$7.2M |
| 3 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$6.19M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$5.92M |
| 5 |
Qiagen
QGEN
|
$5.17M |
Top Sells
| 1 |
Aldeyra Therapeutics
ALDX
|
$7.59M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$6.09M |
| 3 |
CareDx
CDNA
|
$5.7M |
| 4 |
Haemonetics
HAE
|
$5.22M |
| 5 |
MEI Pharma
MEIP
|
$5.05M |
Sector Composition
| 1 | Healthcare | 81.19% |
| 2 | Financials | 8% |
| 3 | Technology | 1.97% |
| 4 | Industrials | 1.26% |
| 5 | Communication Services | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Esperion Therapeutics
ESPR
$448M
| $12.6M | 3.47% | +2,515,785 | New | +$12.6M |
|
2
Protagonist Therapeutics
PTGX
$3.67B
| $11.8M | 3.26% | 346,000 | – | – |
|
|
BLU
3
DELISTED
BELLUS Health Inc.
BLU
| $11.7M | 3.22% | 1,450,006 -338,783 | -19% | -$2.73M |
|
|
BCYC
4
Bicycle Therapeutics
BCYC
$511M
| $10.5M | 2.89% | 172,000 +80,000 | +87% | +$4.87M |
|
5
Crinetics Pharmaceuticals
CRNX
$2.92B
| $9.4M | 2.59% | 331,000 +138,000 | +72% | +$3.92M |
|
|
KDNY
6
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.89M | 2.45% | 545,000 +80,000 | +17% | +$1.3M |
|
7
Lantheus
LNTH
$3.73B
| $7.86M | 2.17% | 272,000 -18,000 | -6% | -$520K |
|
|
POL.WS
8
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $7.39M | 2.04% | 6,103,824 -782,776 | -11% | -$947K |
|
|
PEPL
9
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $7.2M | 1.99% | +735,000 | New | +$7.2M |
|
10
Keros Therapeutics
KROS
$618M
| $6.79M | 1.87% | 116,000 -10,000 | -8% | -$585K |
|
11
Illumina
ILMN
$15.8B
| $6.66M | 1.84% | 17,500 +7,500 | +75% | +$2.85M |
|
12
Immatics
IMTX
$619M
| $6.32M | 1.74% | 469,980 -9,007 | -2% | -$121K |
|
|
NSTG
13
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.19M | 1.71% | +146,500 | New | +$6.19M |
|
|
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
| $5.92M | 1.63% | +1,750,000 | New | +$5.92M |
|
15
Insmed
INSM
$28.8B
| $5.54M | 1.53% | 203,354 | – | – |
|
|
ISEE
16
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.5M | 1.52% | 329,101 +1,000 | +0.3% | +$16.7K |
|
|
CTIC
17
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.42M | 1.49% | 2,185,000 -1,128,000 | -34% | -$2.8M |
|
18
Avidity Biosciences
RNA
$5.99B
| $5.35M | 1.47% | 225,000 | – | – |
|
19
Inspire Medical Systems
INSP
$2.77B
| $5.29M | 1.46% | 23,000 -3,000 | -12% | -$690K |
|
20
Myriad Genetics
MYGN
$593M
| $5.24M | 1.45% | 190,000 +32,000 | +20% | +$883K |
|
|
21
Qiagen
QGEN
$10.1B
| $5.17M | 1.43% | +93,000 | New | +$5.17M |
|
|
MBTC
22
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
| $5M | 1.38% | 500,000 | – | – |
|
23
QuidelOrtho
QDEL
$1.95B
| $5M | 1.38% | +37,000 | New | +$5M |
|
24
ESSA Pharma
EPIX
$11.4M
| $4.9M | 1.35% | +345,000 | New | +$4.9M |
|
25
Celldex Therapeutics
CLDX
$1.47B
| $4.87M | 1.34% | 126,000 -59,000 | -32% | -$2.28M |
|